200HO11586 EINSTEIN

Print/PDF
Registration Name SILVERRIDGE V EINSTEIN-ET
Registration Number HOCAN000012857528
Primary NAAB Code 200HO11586
Secondary Code(s) 777HO11586, 517HO11586, 518HO11586, 722HO11586, 723HO11586
Status Active AI Sire
Controller Name Semex Alliance (200)
Date of Birth 4/18/2018
aAa 534126
DMS 345
GFI 12.9%
Genetic Codes * TD TY TL TV TR TP TC TE
Haplotypes HH1T, HH2C, HH3T, HH4T, HH5T, HH6T
Sire PROGENESIS TOPNOTCH-ET
MGS S-S-I MONTROSS DUKE-ET
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin -
INDEXES
NM$ 604, 91% R CM$ 635
NM Percentile 70% FM$ 537
GTPI 3197 GM$ 566
PRODUCTION TRAITS
5837 Dtrs 923 herds 43 % US 99% R
Milk 858 Fat, % 78 , +0.16%
SCS 2.7, 99% R Protein, % 43 , +0.05%
Feed Saved -307 , 58% R Milking Speed 6.88 , 93% R
Health & Fertility
Productive Life 3.5      98% R Mastitis 1.4      94% R
Heifer Livability 0.0       84% R Metritis 0.9      90% R
Livability 0.2      89% R D. Abom -0.1      94% R
DPR 0.3      97% R Ketosis 1.6      87% R
HCR 1.4      96% R R. Placenta 0.5      91% R
CCR 1.7      97% R Milk Fever -0.2      78% R
SCR 1.6      96% R
Calving Traits
Sire CE 1.5      99% R 6995 Obs
Daughter CE 1.7      97% R 1744 Obs, 2538 Dtrs
Sire SB 4.2      97% R 7744 Obs
Daughter SB 4.4      97% R 1704 Obs, Dtrs
Gestation Length -0.9      99% R 329 Obs, 5055 Dtrs
Early First Calving 2.4      95% R 235 Obs, 1991 Dtrs

CDCB August 2025; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2025
2688 Dtrs 578 herds 99% R
PTA Type 0.54 UDC 1.09
FLC -0.61 BWC 1.09
Linear Traits
Stature -0.02
Short
Strength 0.95
Weak
Body Depth 0.52
Deep
Dairy Form -0.15
Closed
Rump Angle 0.19
Sloped
Thurl Width 1.76
Wide
Rear Legs-Side View -1.67
Straight
Rear Legs-Rear View -1.06
H.-in
Foot Angle 0.04
Steep
Feet & Legs Score -0.39
Low
F.U. Attachment 0.08
Strong
Rear Udder Height 1.02
High
Rear Udder Width 2.54
Wide
Udder Cleft 1.84
Strong
Udder Depth 0.07
Shallow
Front Teat Placement 1.01
Close
Rear Teat Placement 1.58
Close
Teat Length 0.69
Long
-2
0
2

CDCB August 2025; Base of Evaluation: HO